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Cerebellar development occurs mainly postnatally and implies
cell proliferation and migration. Hepatocyte growth factor (HGF)
and Met are involved in mediating these responses in other
tissues and are coexpressed in the cerebellum. Here we show
that Met is localized in granule cell precursors and that cultures
of these cells respond to HGF with proliferation. To study the
role of HGF and Met in the cerebellum in vivo, we produced
a viable hypomorphic Met mutant by knocking in the met locus
a point mutation to abrogate the receptor Grb2-binding site. A
similar mutant was previously described as perinatal lethal. In
this ‘‘first-generation’’ knock-in the recombinant locus retained
the Neo cassette (Metgrb2grb2neo). In the knock-in presented
here Neo was Loxed and excised by Cre recombinase, which led
to higher tissue levels of Metgrb2 protein, sufficient to rescue
viability. In Metgrb2grb2neo mice the size of the cerebellum was
reduced and foliation defects were evident, especially in the
central and posterior half of the vermis. Proliferation of granule
precursors in vivo was 25% lower than in controls. In cultures of
mutant granule cells HGF-induced microtubule-associated pro-
tein kinase activation was reduced and transient. Behavioral
tests indicated a balance impairment in Metgrb2grb2neo mice.
Altogether these data indicate that normal cerebellar develop-
ment and, possibly, function, require HGF and Met, and that
proliferation of granule cells in the cerebellum critically depends
on full HGFMet signaling.
The postnatal development of the cerebellum, which consistsof several layers characterized by distinct cell types, involves
extensive proliferation of granule cell precursors, their inward
migration, and selective loss by apoptosis of excess granule
neurons. These events depend on multiple cell–cell interactions
and are controlled by diffusible factors, both of autocrine and
paracrine origin. In the past few years the identity of some of
these molecules has been unraveled. Sonic hedgehog (Shh), a
molecule which in early development is involved in cell fate
determination, postnatally is made by Purkinje cells and acts as
a potent mitogen for granule cell precursors, both in vitro and in
vivo (1–3). The neurotrophins neurotrophin-3 and brain-derived
neurotrophic factor (BDNF) are both essential for the survival
of granule neurons in vivo (4, 5). Furthermore, several growth
factors originally identified for their activity outside of the
nervous system, such as epidermal growth factor, basic fibroblast
growth factor, and insulin-like growth factor-1 (IGF-1), have
been reported to stimulate proliferation andor survival of
granule cell precursors in vitro (6–8). Among these factors is
also hepatocyte growth factor (HGF), which has been shown
to protect cultured rat cerebellar neurons from apoptotic cell
death (9).
Several studies (10–12) have shown that HGF and its receptor
Met, better known for contributing to the formation of placenta,
liver, and muscle during embryogenesis, also participate in
neuronal cell development (13). In this work we wanted to
establish whether the HGFMet pair plays a role in cerebellar
development and function. Early studies localized HGF protein
to Purkinje cells and met mRNA to granule cells of the cere-
bellum (14). We first reassessed Met expression in postnatal
cerebellum and verified the response of cerebellar granule cells
to HGF in vitro. To extend our analysis to an in vivo model, we
then produced a viable partial loss-of-function Met mutant. This
mutant was obtained by knocking in the met locus a point
mutation that interferes with binding of the Grb2 adapter to the
receptor, and thus impairs its ability to activate the Ras
microtubule-associated protein (MAP)-kinase cascade (15–17).
We found that Met is expressed in proliferating cells of the
external granule layer (EGL) of the cerebellum and that primary
cultures of granule cells respond to HGF with an increase in
proliferation. In the mutant with a partial loss of Met function
the cerebellum was smaller than in controls and showed abnor-
mal foliation. Furthermore, EGL granule cells proliferation
was reduced, and a test for cerebellar function indicated a
balance impairment. We conclude that HGF and Met are
necessary to promote proliferation of granule cell precursors
during postnatal development and may be involved in mediating
cerebellar function.
Methods
Immunofluorescence. Cerebella were removed from the skulls,
embedded in OCT, and rapidly fresh-frozen in isopentane.
Sections (15 m) were fixed in 20°C methanol and saturated
in PBS with 5% goat serum, 0.1% Tween. Primary antibodies
were added at a dilution of 1:300 for anti-mouse Met (Santa Cruz
Biotechnology, rabbit polyclonal) and for anti-proliferating cell
nuclear antigen (Santa Cruz Biotechnology, mouse monoclo-
nal), and incubated overnight at 4°C. After washing, Cy3 sec-
ondary anti-rabbit antibody (1:1,200, Roche Molecular Bio-
chemicals) or FITC secondary anti-mouse antibody (1:50, Roche
Molecular Biochemicals) were added and incubated for 1 h at
room temperature.
Western Blot. Postnatal day (P) 8 cerebella or embryonic day (E)
13.5 embryos were homogenized and lysed in ice-cold RIPA
buffer (0.15 mM NaCl0.05 mM TrisHCl, pH 7.21% Triton
X-1001% sodium deoxycholate0.1% SDS) with Sigma Pro-
tease Inhibitor Mixture. Primary cerebellar granule cells were
lysed in ice-cold EB buffer (1% Triton10 mM TrisHCl, pH
7.5150 mM NaCl5 mM EDTA10% glycerol) with Sigma
Protease Inhibitor Mixture. Protein concentration was deter-
mined by the BioRad DC protein assay and equal amounts of
protein were separated on SDSPAGE. Proteins were trans-
ferred to a poly(vinylidene difluoride) membrane (Amersham
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Pharmacia) followed by blocking in 5% low-fat milk. Membranes
were incubated with anti-mouse Met or anti-human Met
(1:10,00, Santa Cruz Biotechnology, rabbit polyclonal), anti-
phospho-MAP-kinase (1:10,000, Sigma, mouse monoclonal), or
anti-actin (1:50,00, Sigma, mouse monoclonal) antibodies over-
night at 4°C. After washing, filters were incubated with perox-
idase-conjugated secondary anti-mouse or anti-rabbit antibody
(1:4,000, Amersham Pharmacia). The signal was revealed by
ECL (Amersham Pharmacia) or Supersignal (Pierce).
Dissociated Cerebellar Cell Cultures. Cerebella were removed from
P6 mice, and granule cell cultures were prepared as described in
ref. 9. Cells were cultured in serum-containing medium (Basal
Medium Eagle supplemented with 10% FCS25 mM KCl1
g/liter glucose2 mM L-glutamine100 units/ml penicillin100
units/ml streptomycin) for biochemical analysis, or serum-free
medium without KCl for proliferation analysis. Cells were
seeded into 35-mm dishes or 96-multiwell plates coated with
poly-D-lysine.
BrdUrd Incorporation in Vitro. Cerebellar cells isolated as described
above were resuspended in serum-free medium and transferred
to poly-D-lysine-coated 96-well plates, at a density of 75,000 cells
per well. Growth factors were added immediately, and cells were
cultured for 46 h. Cells were pulsed with BrdUrd at 24 h of
culture. The amount of BrdUrd incorporation was quantified by
using the Cell Proliferation kit (Roche Diagnostics) according to
the manufacturer’s recommendations.
Generation of Met Mutant Mice. The targeting vector was as
described in ref. 12, except that the Neo cassette was flanked by
LoxP sites for Cre-mediated excision in vivo (18). Cell culture,
electroporation of R1 embryonic stem (ES) cells, and selection
with G418 and GANCR were done as described (12). Pools of six
individual G418R ES cell clones were tested for homologous
recombination by PCR by using primer 1–2 (see Fig. 2). For
Southern blot analysis, DNA (20 g) was digested with NdeI,
electrophoresed on a 0.6% agarose gel, and blotted on nylon
membranes. Blots were hybridized with a 32P-labeled 1.2-kb
probe deriving from genomic sequences located upstream of the
5 end of the targeting vector (see Fig. 2). Double-selected
recombinant ES cells were morula-aggregated in an external
facility, and three chimeric animals were obtained, all capable of
transmitting the recombinant gene. Mice were genotyped by
PCR using primers 3 and 4. Removal of the Neo cassette, after
crossing with the Cre Deleter (18), was assessed by PCR using
primer 1 in the Neo cassette and primer 5 (see Fig. 2). Neo
mutants were crossed with SV129 mice. Mutants free from Cre
recombinase were selected by PCR. Mice used in this work were
obtained by successive backcrossing of the F2 generation.
Cresyl Violet Staining. Brains were dissected, fixed for 24 h at 4°C
in PBS containing 4% paraformaldehyde, dehydrated, and em-
bedded in paraffin. Sections (6–8 m) were cut and stained with
cresyl violet.
Immunohistochemistry: BrdUrd Incorporation in Vivo. BrdUrd was
injected i.p. 2 or 72 h before death. Brains were dissected and
fixed in 4% paraformaldehyde overnight, dehydrated, and em-
bedded in paraffin. Sections (6–8 m thick) were rehydrated,
microwaved for 15 min in 10 mM citrate buffer, pH 6, and treated
with 2 M HCl at room temperature for 1 h. They were then
saturated in PBS with 5% goat and 5% sheep serum, 0.5% Triton
for 30 min, and finally incubated with an anti-BrdUrd mAb (1:50,
Roche Molecular Biochemicals) overnight at 4°C. For calbindin
staining sections were incubated with anti-calbidin polyclonal
antibody (1:3,000, Swant, Bellinzona, Switzerland) overnight at
4°C. For both stains, after extensive washing, sections were
incubated with biotinylated goat anti-mouse or anti-rabbit IgG
(1:800, Roche Molecular Biochemicals) for 1 h, washed again,
and finally incubated with peroxidase-conjugated streptavidin.
Staining was visualized with diaminobenzidine (Sigma).
Thin Rod Test. The stationary horizontal thin rod test was per-
formed as described in ref. 19 on age- and sex-matched animals.
Results
Met Receptor Expression in the Cerebellum. Met and HGF are
expressed in the adult cerebellum (14). To determine whether
they could play a role during cerebellar development we first
examined Met expression at P8, at the peak of granule cell
proliferation. Western blots were done on extracts of cerebellum,
with liver as a positive control for Met expression. Met was
present in both tissues, visualized as a band migrating at 145
kDa (the Met -chain) (Fig. 1A). Its localization was assessed
by immunofluorescence. In cerebellar sections from P8 mice,
Met was localized in the EGL (Fig. 1 B and C). Double
immunofluorescence with antibodies against Met and prolifer-
ating cell nuclear antigen revealed colocalization of the two
proteins (Fig. 1F). The finding that Met is expressed in prolif-
erating granule cells suggests a role for the HGFMet pair in
cerebellar development.
HGF Is a Mitogen for Granule Cells in Vitro. We used primary cultures
of cerebellar cells to test whether HGF was capable of stimu-
lating granule cell proliferation in vitro. Cells derived from the
cerebellum of P6 mice were incubated for 24 h with or without
different amounts of HGF (5–50 ngml) and pulsed for 22 h with
BrdUrd. IGF-I was used as a positive control. Incorporation of
BrdUrd was quantified by an ELISA colorimetric method. As
shown in Fig. 1D, HGF caused a 2- to 3-fold increase in
proliferation, whereas the effect of IGF-I was more potent.
Combined addition of HGF and IGF-1 did not result in a
synergistic effect (not shown).
Generation of Partial Loss-of-Function Met Mutant Mice by Homolo-
gous Recombination. Having confirmed that Met is expressed by
proliferating cells in postnatal cerebellum at a stage critical for
Fig. 1. Expression and localization of Met in the cerebellum, and prolifer-
ative response of granule cell cultures to HGF. (A) Western blot of mouse
cerebellum and liver extracts at P8 (p145 m-Met: mouse Met, specifically
detected by anti-mouse Met antibody). Neg. control: cerebellum from genet-
ically modified mice expressing a mouse-human Met-chimera (see Fig. 2). (B)
Anti-m-Met immunostaining revealing expression in the EGL. (C) Phase con-
trast showing cerebellar morphology. (E) Pretreatment of the antibody with
cognate peptide. (F) Double staining with anti-Met (red) and anti-
proliferating cell nuclear antigen (green) showing coexpression. (B, C, and E,
20; F, 40.) (D) BrdUrd incorporation in HGF- or IGF-1-treated cerebellar
granule cell cultures from P6 mice. Three experiments were performed in
quadruplicate and values are shown as mean  SEM.








its development, and that granule cells respond to HGF in vitro
with increased proliferation, we next wanted to verify these
observations in an in vivo model. Both the Met and HGF
knockouts are embryonal lethal (10–12), thus we aimed at
obtaining a viable hypomorphic mutant by means of a partial loss
of Met function. To this end we produced a different version of
a targeting vector described in ref. 12, previously used to
generate by homologous recombination a knock-in mouse with
a point mutation in the Met Grb2 binding site (Metgrb2:
Y1356VNV3Y1356VHV). In both the original and our version of
the targeting vector, a mutated human MET cDNA fragment
coding for the transmembrane and cytoplasmic domain of the
receptor, followed by the Neo cassette, was inserted in-frame in
a mouse genomic clone (Fig. 2A). In the ‘‘first-generation’’
Metgrb2 mice the Neo cassette remained in the recombinant locus.
These mutants were perinatal lethal when homozygous, with
rare individuals surviving into adulthood (12). Subsequent work
has shown that retention of Neo in the recombinant locus causes
a decreased level of mutant Met receptor in some tissues (20).
Thus in our version of the targeting vector, LoxP sites were
introduced to flank the Neo cassette (Fig. 2 A) to allow its
excision on crossing of Metgrb2neomice with the Cre Deleter strain
(18). Double-selected ES cells were screened by PCR and
Southern blot analysis (Fig. 2B). Recombinant ES cells were
morula-aggregated to produce chimeric mice. Three chimerae
gave germ-line transmission of the recombinant locus. Heterozy-
gous mice were crossed with the Cre Deleter strain (in the SV129
genetic background) for excision of the Neo cassette. Mice
without Neo were identified by PCR and crossed with wild-type
(WT) SV129 mice. Heterozygous Metgrb2neo mice without the
Cre Deleter gene were selected by PCR.
Homozygous Metgrb2/grb2neo mice showed a phenotype sim-
ilar to first-generation mutants. At birth they were easily distin-
guishable from littermates because of their hyperflexed fore-
limbs (due to reduction of extensor muscles; ref. 12), and
they died in a few hours. After Neo removal, homozygous
Metgrb2/grb2neo mice had normal forelimbs and were viable. To
compare the amount of Met protein in the Metgrb2/grb2neo and
Metgrb2/grb2neo mutants, protein extracts of E13.5 embryos were
analyzed by Western blot by using an antibody specific for the
carboxyl terminus of human Met. Fig. 2C shows that the level of
Met receptor was higher in the Metgrb2/grb2neo embryos, which
suggests that the increase in expression of the mutated Met
receptor after Neo excision is most likely responsible for the
rescue of viability of Metgrb2/grb2neo mice and indicates that, in
the presence of an adequate amount of receptor, the net effect
of the mutation (if any) must be very subtle.
Abnormal Foliation in Cerebellum of Metgrb2/grb2neo Mutants. All
members of the Met family, Met, Ron, and Sea, share the
sequence YVNV in their multidocking site (21). The conserva-
tion of the optimal motif for Grb2 binding (YXNX) suggests
that a direct link with Grb2 is essential for proper functioning
of these receptors. For this reason, although Metgrb2/grb2neo
mice lacked obvious defects, we felt that these mutants deserved
to be analyzed in depth, searching for a phenotype which,
although weak, could still be informative. The cerebellum of the
Metgrb2/grb2neo mutants was first examined morphologically. Its
appearance and organization was compared with that of WT
littermates at P23, when development is complete. The cerebel-
lum of mutant mice was significantly smaller than that of controls
(Fig. 3 A and B). Cerebellar weight was reduced by 20%,
whereas no statistically significant difference was found in brain
weight (not shown).
Histological analysis showed that in Metgrb2/grb2neo mutants
the layers of the cerebellum formed normally, with the appro-
priate cells types. However, the mutants, compared with their
WT littermates, displayed abnormalities in foliation. By P23, WT
animals develop a mature foliation pattern within the vermis,
with the characteristic folia separated by well-defined fissures
(Fig. 3C). In Metgrb2/grb2neo mutants the fissures in the anterior
portion of the cerebellum were normal in size, whereas defects
were evident in the median and posterior portions of the
cerebellum. The declival sulcus (dcl) and the intercrural fissure
(itc) were reduced or absent, whereas the secondary fissure (scd)
and the posterolateral (plt) fissure were reduced to a lesser
extent (Fig. 3D). Quantitative analysis confirmed that the de-
crease in depth of each of these fissures in mutant animals at P23
was statistically significant (Fig. 3E). Because recent findings on
the cerebellar-deficient folia (cdf) mouse mutant show that
abnormal foliation may be caused by a defect intrinsic to a subset
of Purkinje cells (resulting in their ectopic placement) rather
than to granule cells (22, 23), we verified their location and
morphology in the Metgrb2/grb2neo mutant. Purkinje cells in the
mutant mice were correctly positioned and were indistinguish-
able from controls (Fig. 3 F and G).
Cerebellar Granule Cell Proliferation Is Decreased in Metgrb2/grb2neo
Mutants. During the early postnatal period cells in the EGL
undergo extensive proliferation and generate a large pool of
granule cell precursors. To investigate whether HGF affects
proliferation of these cells, BrdUrd incorporation, a marker for
DNA synthesis, was analyzed in vivo in Metgrb2/grb2neo mutants.
BrdUrd was injected i.p. in P8 or P7 mice, and the animals were
killed 2 or 72 h later. The cerebellum was dissected and prepared
for histological analysis. The proliferative index in the EGL was
determined by counting BrdUrd-positive versus total cells in
Fig. 2. Knock-in of YVNV3YVHV signaling mutation (Metgrb2) in the met
locus. (A) Schematic representation of the knock-in strategy. Black boxes
represent exons. N indicates NdeI sites. The Neo cassette was flanked by LoxP
sites (triangles). Asterisk indicates the location of the mutation. Arrows indi-
cate primers used for screening of ES (1 and 2) and Neo alleles (1 and 5), and
for genotyping mice heterozygous for the Metgrb2 mutation (3 and 4). (B)
Southern blot of NdeI digests of genomic DNA isolated from double-selected
R1 ES cell clones [, WT ES; , control recombinant ES cells used for
production of first-generation Metgrb2 mice (see text); 1–3, recombinant
ES clones]. (C) Western blots of total protein extracts from E13.5 WT,
Metgrb2/grb2neo, and Metgrb2/grb2neo embryos. h-Met, antibody specific for
human Met; Actin, anti-actin (control for protein loading).
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sections of mutant and control mice killed 2 h after injection. In
the mutant mice proliferation was 25% reduced with respect
to controls (Fig. 4A). Similar results were obtained by evaluating
BrdUrd incorporation 72 h after injection (not shown). Analysis
at this later time also showed that in the mutants no delay
occurred in migration of BrdUrd-positive cells. In fact, BrdUrd-
labeled cells were all found in the internal granule layer rather
than in the molecular layer, in the mutants as in the controls (Fig.
4 B and C). The reduction in granule cell proliferation was
similar throughout the cerebellum, with no significant differ-
ences in the areas more heavily affected morphologically.
HGF acts as a survival factor for granule cells in vitro (9). To
assess whether in Metgrb2/grb2neo mice granule cell survival was
impaired, parasagittal sections of P8 cerebella from mutant and
control mice were terminal deoxynucleotidyltransferase-mediated
dUTP nick end labeling (TUNEL)-stained. Quantitative analysis of
total cell death did not reveal any significant difference between the
number of apoptotic cells in mutant and control mice (56  18.3
versus 57.3  13.8 TUNEL-positive cells per section).
These data altogether indicate that HGF induces proliferation
in granule cell precursors and suggest that direct recruitment of
Grb2 by the Met receptor is important for a full proliferative
response in the EGL. Conversely, granule cell migration and
survival are either HGF independent or do not require full Met
signaling.
HGF-Induced MAP-Kinase Activation Is Impaired in Cerebellar Granule
Cells from Metgrb2/grb2neo Mutants. The Grb2 adapter is recruited
to tyrosine kinase receptors through its Src homology 2 domain
and binds the Ras guanine nucleotide exchanger Sos by way of
the N-terminal Src homology 2 domain (24). Thus receptors with
a Grb2-binding site can activate the RasMAP-kinase cascade
directly. It has been shown in transfected fibroblasts that un-
coupling Met from Grb2 lowers the HGF-dependent MAP-
kinase response, and that full activation of the Ras pathway is
necessary to promote cell proliferation (15, 17).
To investigate whether in cerebellar granule cells from
Metgrb2/grb2neo mice the RasMAP-kinase cascade is impaired,
primary granule cell cultures from P6–P8 mutant and WT
mice were treated with HGF or BDNF, used as control, for
different times. Activation of the Ras pathway was assessed by
evaluating phosphorylation of the downstream effector MAP
kinase. As shown in Fig. 5A, HGF-induced MAP-kinase
phosphorylation was weaker in mutant granules than in con-
trol cells. Densitometric analysis of the blots showed that in
WT cerebellar cultures MAP kinase activity peaked 15 min
after stimulation, and was sustained for more than an hour. In
granule cells obtained from Metgrb2/grb2neo mutants, the peak
at 15 min was reduced and MAP-kinase activation was tran-
sient. Conversely, the pattern of BDNF-induced MAP-kinase
phosphorylation was the same in WT and Metgrb2/grb2neo
granule cells (Fig. 5 C and D). These data show that in primary
cultures of mutant granule cells HGF-mediated activation of
the RasMAP-kinase cascade is decreased. Because this effect
is specific for HGF stimulation it must be a consequence of the
mutated Met protein and is likely to be caused by the loss of
the Grb2-binding site.
Impaired Cerebellar Function in Metgrb2/grb2neo Mutants.
Metgrb2/grb2neo mutants and WT littermates were indistinguish-
able with respect to behavior when observed in their normal
cage environment. However, subtle defects in balance control
can emerge if animals are subjected to tests such as the
thin-rod horizontal stationary test (19). In this test mice are
put on a suspended rod and the time of permanence on it is
measured. Three consecutive trials were performed for 5 days.
Fig. 3. Macroscopic analysis of Metgrb2/grb2neo cerebellum. (A and B) Cere-
bellum from WT (A) and Metgrb2/grb2neo mutant (B) at P23. (C and D) Sagittal
sections of cerebellum from P23 WT (C) and mutant mice (D) stained with
cresyl violet (1.6). Cerebellar fissures and sulci: plt, posteriolateral; uvu,
uvular; scd, secondary; ppy, prepyramidal; itc, intercrural; dcl, declival; pri,
primary; pcu, preculminate; pct, precentral. (E) Fissure depth was analyzed by
using the IMAGE PRO PLUS system (Media Cybernetics, Silver Spring, MD). Six
mutants and five controls were analyzed. Values are shown as mean  SEM.
t test: *, P 0.02; **, P 0.01; ***, P 0.001. (F and G) Calbindin staining of
Purkinje cells at P8 in control (F) and Metgrb2/grb2neo mice (40).
Fig. 4. BrdUrd incorporation in the cerebellum of Metgrb2/grb2neo mutants.
(A) P8 mice were injected with BrdUrd and killed 2 h later. Sections were
stained by immunohistochemistry using anti-BrdUrd antibodies. BrdUrd-
positive cells were counted in at least six regions of the EGL (3,000–4,000 cells
per cerebellum). Five mutant and three control mice were analyzed and values
are shown as meanSD. t test: P0.0001. (B and C) P7 mice were injected with
BrdUrd and killed 72 h later (20). Black, BrdUrd-positive cells; light blue,
hematoxylin-stained nuclei; ML, molecular layer; PL, Purkinje layer; IGL, inter-
nal granule layer.








WT and Metgrb2/grb2neo mutants showed clear differences in
performance (Fig. 6). However, although the average perma-
nence time was reduced in Metgrb2/grb2neo mutant mice, the
slope of the learning curve was comparable, suggesting no
major defects in cerebellar learning.
Discussion
Cerebellar development involves a proliferative and a migratory
wave during which granule cell precursors actively divide and
subsequently, when postmitotic, migrate inward to their final
destination. Some of the molecules that regulate these and other
events, such as protection from apoptotic death, which occurs to
eliminate supranumerary cells, are just beginning to be identi-
fied. Among these molecules are a number of neurotrophins and
growth factors, such as neurotrophin-3, BDNF, epidermal
growth factor, IGF-1, and basic fibroblast growth factor, which
bind to receptors of the tyrosine kinase superfamily. The pattern
of expression and biological activity of another member of this
family, the Met receptor, which in response to HGF controls
proliferation andor migration of a vast array of cell types (25),
suggest that this ligand–receptor pair could contribute to cere-
bellar development as well.
In this work we first confirmed that Met is indeed expressed
by granule cell precursors in the EGL and that cultured granule
cells respond to HGF. Previous work by others had shown that
HGF prevents apoptotic death in cultured cerebellar granule (9).
Because several other growth factors, such as epidermal growth
factor, IGF-I, and Shh, can induce granule cell proliferation in
vitro (1–3, 6, 7), we focused on the proliferative response.
Addition of HGF to primary granule cell cultures caused a 2- to
3-fold increase in the number of BrdUrd-positive cells. In our
experimental conditions the proliferative effect of HGF was
significant, but relatively small compared with that observed
with IGF-1. In other systems, such as cultures of motor or
sensory neurons, HGF requires the presence of ciliary neuro-
trophic factor or nerve growth factor to efficiently promote
survival (26, 27). In our cultures we tried combining it with
IGF-1, without any synergistic effect. This result leaves open the
possibility that in vivo, where HGF could act in combination with
other factors, its effects on granule cells could be more dramatic.
In vitro experiments may be highly suggestive, but unequivocal
proof for function comes only from in vivo studies. Loss-of-
function models for growth factors or their receptors are fre-
quently lethal in homozygosity, and lethality poses a problem
when, as in the cerebellum, the events under study occur
postnatally. The HGF and Met knockouts are lethal in midges-
tation and thus uninformative in terms of cerebellar develop-
ment. A knock-in mouse with a point mutation in the Met
receptor that impairs signal transduction through the RasMAP-
kinase pathway (Metgrb2) was described (12). This study also
included a knock-in expressing the WT receptor as a control
(Metwt). Although Metwt/wt mice were normal, Metgrb2/grb2 mice
had a muscle phenotype (affecting limbs, tongue, and dia-
phragm) milder than the knockouts, but still perinatal lethal
(12). Occasionally a few Metgrb2/grb2 mice developed into adults,
suggesting that this model was borderline for survival. We later
showed that retention of the Neo cassette in the met locus (as in
these genetically modified mice) results in reduced level of Met
protein in some tissues (20). The lack of phenotype in Metwt/wt
mice suggests that reduced level is without effect in the presence
of a normal Met receptor. However, such reduction could well
‘‘sensitize’’ the system, exacerbating the effect of a signaling
mutation. In the present work we describe a ‘‘second-
generation’’ Metgrb2/grb2neo mutant, obtained by removing
the Neo cassette by Cre recombinase. In Metgrb2/grb2neo embryos
the level of Metgrb2 protein was indeed higher than in
Metgrb2/grb2neo embryos, which was sufficient to rescue their
muscle phenotype and viability, thus allowing analysis of post-
natal cerebellar development.
Morphological analysis showed that the cerebellum of
Metgrb2/grb2neo mice was small and with an abnormal pattern of
foliation. The foliation defect was much more evident in the
middle and posterior regions of the cerebellum. Previous work
has shown a relation between foliation and changes in granule
cell proliferation andor viability. Hyperproliferation of gran-
ule cells in transgenic mice overexpressing Zipro1 or IGF-I
results in excess foliation (28, 29), whereas enhanced apoptosis
Fig. 5. HGF-dependent MAP-kinase phosphorylation in Metgrb2/grb2neo. (A
and C) Representative Western blots of extracts of cerebellar granule cell
cultures from P6 WT and mutant mice, stimulated with HGF (20 ngml) (A) or
BDNF (100 ngml) (C) for the indicated times. Blots were probed with
antiphospho-MAP kinase, stripped, and reprobed with an antibody against
-actin for normalization. (B and D) Densitometric analysis of the Western
blots. Scanned films were analyzed with the IMAGE MASTER TOTAL LAB V100 program
(Amersham Pharmacia) and plotted with Microsoft EXCEL. Values were ob-
tained from eight different experiments and are presented as mean  SEM.
Fig. 6. Cerebellar function in Metgrb2/grb2neo mutant mice. WT and mutant
mice were tested for equilibrium and coordination by the thin-rod test. The
time spent on the rod up to a limit of 60 s was measured. Nine animals for
each genotype were tested in a total of 15 sessions. Values are shown as
mean  SEM.
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of granule neurons in BDNF or neurotrophin-3 mutant mice
results in foliation defects similar to those observed in the
Metgrb2/grb2neo mutant (4, 5). We thus asked whether prolif-
eration andor apoptosis were altered in the cerebellum of
Metgrb2/grb2neo mice. Our results showed that in these mutants
abnormal foliation is associated with a 25% reduction of
granule cell precursors proliferation in the EGL.
In our mutants, altered cerebellar foliation seems not to be
caused by an increase in cell death, because quantification of
apoptotic cells by TUNEL staining did not reveal significant
differences compared with WT mice. A previous report showed
that in vitro HGF-induced survival of granule neurons depends
on phosphatidylinositol 3-kinase rather than on MAP-kinase
activation (9).
It has been shown that HGF may have a role as motogenic
factor for interneurons of the cerebral cortex. In fact, in u-PAR
(urokinase-type plasminogen activator receptor) null mice,
which have a low level of Met and HGF expression, the migration
of interneurons is altered (30). In tPA (tissue plasminogen
activator) null mice, a delay occurs in granule cell migration
during cerebellar development (31). Both u-PA and tPA are
proteases that in vitro can cleave pro-HGF to the mature
biologically active two-chain form. In our Metgrb2/grb2neo mutant
we did not observe any delay in granule cell migration. The same
number of BrdUrd-positive cells were still traversing the molec-
ular layer (en route toward the internal granule layer) 72 h after
injection in the mutant and the WT control.
In the Metgrb2/grb2neo mutant the Met receptor cannot recruit
the Grb2 adaptor directly. Grb2 is associated with the Ras
exchanger Sos, and thus allows the receptor to activate
the RasMAP-kinase pathway. We provide biochemical evi-
dence that in primary granule cell cultures obtained from
Metgrb2/grb2neo mice, MAP-kinase phosphorylation after HGF
stimulation was lower and more transient than in controls.
These data are consistent with those previously obtained in
transfected cells showing that a direct link of Grb2 with Met
is necessary to activate fully the RasMAP-kinase cascade and
to promote proliferation (15–17). The decrease in MAP-
kinase activation andor its transient quality is likely to be
responsible for the reduction of granule cell precursors pro-
liferation observed in vivo. However, the MAP-kinase pathway
may not be the only pathway whose response is impaired
downstream of the Metgrb2/grb2neo mutant, because Grb2 also
contributes to linking Met with the large adapter protein
Gab-1, which in turns amplifies the Met signal by activating
several effectors (reviewed in ref. 32). Furthermore, because
we did not produce a Metwt/wtneo control we cannot formally
exclude that the observed subtle defects could be caused by the
fact that the recombinant Met receptor is a mousehuman
chimera, working as an hypomorph independent of the Grb2
mutation.
Metgrb2/grb2neo mutant mice were indistinguishable, with re-
spect to behavior, from WT littermates when observed in the
cage environment. However, we noticed that they had difficulties
in complex exercises like swimming (not shown), and when tested
in an exercise more specifically devised to assess cerebellar
function such as the thin-rod test. This result suggests an altered
control of balance and complex movements. We do not know if
these defects are a consequence of the observed alterations in
cerebellar development or whether they also indicate a role for
HGFMet in cerebellar function. Further studies, such as pro-
duction of an inducible cerebellar-specific Met knockout are
necessary to clarify this aspect.
In conclusion, our data, gathered from experiments on cere-
bellar cell cultures and a partial loss of function Met knock-in
mouse, indicate that HGF is involved in postnatal development
of the cerebellum. The role of HGF seems to be to promote
proliferation of granule cell precursors in the EGL. Most likely
the Met receptor mediates this effect by recruitment of Grb2,
which is necessary to promote a full proliferative response.
Conversely, a direct link of Met with Grb2 does not seem to be
necessary to promote migration of granule cells in the internal
granule layer, or their survival. However, we cannot exclude that
HGF and Met contribute in vivo to migration andor survival of
granule cells. In fact, our Met mutant confers only a partial loss
of function and the requirement for survival or migration may be
fulfilled by its residual signaling potential.
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